Cushing's syndrome
- PMID: 37984386
- DOI: 10.1016/S0140-6736(23)01961-X
Cushing's syndrome
Abstract
Endogenous Cushing's syndrome results from excess glucocorticoid secretion, which leads to a myriad of clinical manifestations, comorbidities, and increased mortality despite treatment. Molecular mechanisms and genetic alterations associated with different causes of Cushing's syndrome have been described in the last decade. Imaging modalities and biochemical testing have evolved; however, both the diagnosis and management of Cushing's syndrome remain challenging. Surgery is the preferred treatment for all causes, but medical therapy has markedly advanced, with new drug options becoming available. Nevertheless, several comorbidities remain even after patient remission, which can affect quality of life. Accurate and timely diagnosis and treatment are essential for mitigating chronic complications of excess glucocorticoids and improving patient quality of life. In this Seminar, we aim to update several important aspects of diagnosis, complications, and treatment of endogenous Cushing's syndrome of all causes.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests MG has received funding as principal investigator from Crinetics and Recordati in the last 3 years, has received personal honoraria for lectures, consulting, and advisory boards from Crinetics and Recordati, and is an Associate Editor of The Journal of Clinical Endocrinology and Metabolism. FG is an Associate Editor of Frontiers in Endocrinology (Translational Endocrinology), serves on the Executive Committee of the European Neuroendocrine Association, and has received personal honoraria for lectures, manuscript writing, and educational events from Ipsen, Novartis, Pfizer, and Recordati. LEW has received personal honoraria for lectures from Ipsen and is on the advisory board for Crinetics. MF has received funding from Crinetics, Recordati, Sparrow, and Xeris (previously Strongbridge) in the last 3 years as a principal investigator at the Oregon Health & Science University, has received personal honoraria for consulting and acting on advisory boards from Crinetics, HRA Pharma, Recordati, Sparrow, and Xeris (previously Strongbridge), is Deputy Editor of the European Journal of Endocrinology, and serves on the board of the Pituitary Society.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical